Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)
- Status
- TERMINATED
- Phase
- PHASE3
Investigator-initiated Clinical Trial of MIKE-1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids
- Status
- RECRUITING
- Phase
- PHASE2
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
AB122 Platform Study
- Status
- RECRUITING
- Phase
- PHASE1
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Study of Lacutamab in Peripheral T-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Using ctDNA to Determine Therapies for Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)
- Status
- WITHDRAWN
- Phase
- PHASE3
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2